Source: colorado.gov
Report by
119 North Fifth Street, Cripple Creek, Colorado, United States
Updated:
Source: colorado.gov
Source: colorado.gov
Source: colorado.gov
Source: colorado.gov
6 individuals tested positive for Covid-19, Wildwood Casino: February 2021, Teller County, CO
3 years ago
Source: colorado.gov
2 individuals tested positive for Covid-19, Wildwood Casino: February 2021, Teller County, CO
3 years ago
Source: colorado.gov
Source: colorado.gov
3 individuals tested positive for Covid-19, Wildwood Casino, 119 N Fifth St, Cripple Creek, CO 80813, USA
3 years ago
Source: colorado.gov
Source: colorado.gov
3 individuals tested positive for Covid-19, Wildwood Casino, 119 N Fifth St, Cripple Creek, CO 80813, USA
3 years ago
Source: colorado.gov
Recent Interesting Reports
Received an item not as described, Montgomery View Drive, Harriman, TN, USA
3 weeks ago •reported by user-vdcpj422
Package I didn't order, Seymour, MO, USA
1 week ago •reported by user-rpzm2696
Unordered Yoshi package, Grand Rapids, MI, USA
4 weeks ago •reported by user-tvnvy824
I received a packet of seeds I didn't order, Industry Cir, Mirada, CA 90638, USA
1 week ago •reported by user-kwwr7591
A package I never ordered, Detroit, MI, USA
2 weeks ago •reported by user-xyhyr989
Ukyousoutlet Scam, Hamilton, New Zealand
6 days ago •reported by user-tpnz6916
Feathers Fottys is an absolute scam, Michigan, USA
3 weeks ago •reported by user-whnhc378
The promo on Facebook was made to look so promising for turkey neck issues and facial wrinkles.
Under Armor shoes which never had not been sent me, Sri Lanka
1 week ago •reported by user-mnmvh657
AvKARE, LLC Atovaquone Oral Suspension - recalled due to potential Bacillus cereus contamination, USA
4 weeks ago •source www.fda.gov
Recall notice
Risk Statement: In the population most at risk, immunocompromised population, there is a reasonable probability that microbial contamination of Atovaquone Oral Suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections.
Atovaquone Oral Suspension, USP is indicated for prevention and treatment of Pneumocystis jiroveci pneumonia (PCP) in adults and children 13 years of age and older who cannot tolerate other medicines, such as trimethoprim-sulfamethoxazole.
The product is packaged in a carton. The identified NDC # associated with the product is 50268-086-12, UPC # 5026808612 and the affected lot# is AW0221A with an expiration date of 08/2025.
AvKARE, LLC is notifying its distributors and wholesale customers by mailings and email communications method and is arranging for returns of all recalled Atovaquone Oral Suspension, USP. Wholesalers who have Atovaquone Oral Suspension, USP 750mg/5mL, which are being recalled, should examine their inventory and cease dispensing, return any of the impacted lots to AvKARE, LLC. Consumers that have product which is being recalled should stop using the product and return it to place of purchase.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: AvKARE, LLC
Brand name: AVpak
Product recalled: Atovaquone Oral Suspension, USP 750mg/5mL
Reason of the recall: Potential Bacillus cereus contamination
FDA Recall date: April 01, 2024
Source: www.fda.gov